Your browser doesn't support javascript.
loading
Predictors and associations of the persistent airflow limitation phenotype in asthma: a post-hoc analysis of the ATLANTIS study.
Kole, Tessa M; Vanden Berghe, Elise; Kraft, Monica; Vonk, Judith M; Nawijn, Martijn C; Siddiqui, Salman; Sun, Kai; Fabbri, Leonardo M; Rabe, Klaus F; Chung, Kian Fan; Nicolini, Gabriele; Papi, Alberto; Brightling, Chris; Singh, Dave; van der Molen, Thys; Dahlén, Sven-Erik; Agusti, Alvar; Faner, Rosa; Wedzicha, Jadwiga A; Donaldson, Gavin C; Adcock, Ian M; Lahousse, Lies; Kerstjens, Huib A M; van den Berge, Maarten.
Afiliação
  • Kole TM; Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, Netherlands; Groningen Research Institute for Asthma and COPD, University of Groningen, University Medical Center Groningen, Groningen, Netherlands. Electronic address: t.m.kole@umcg.nl.
  • Vanden Berghe E; Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, Netherlands; Groningen Research Institute for Asthma and COPD, University of Groningen, University Medical Center Groningen, Groningen, Netherlands; Department of Bioanalysis, Ghent University,
  • Kraft M; Department of Medicine and the Asthma and Airway Disease Research Center, University of Arizona, Tucson, AZ, USA.
  • Vonk JM; Groningen Research Institute for Asthma and COPD, University of Groningen, University Medical Center Groningen, Groningen, Netherlands; Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
  • Nawijn MC; Groningen Research Institute for Asthma and COPD, University of Groningen, University Medical Center Groningen, Groningen, Netherlands; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
  • Siddiqui S; National Heart and Lung Institute, Imperial College London, London, UK.
  • Sun K; Data Science Institute, Imperial College, London, UK.
  • Fabbri LM; Department of Respiratory Medicine and Translational Medicine, University of Ferrara, Ferrara, Italy.
  • Rabe KF; Department of Medicine, Christian Albrechts University of Kiel, Kiel, Germany; LungenClinic Grosshansdorf, Airway Research Center North in the German Center for Lung Research, Grosshansdorf, Germany.
  • Chung KF; National Heart and Lung Institute, Imperial College London, London, UK.
  • Nicolini G; Department of Global Clinical Development, Chiesi Farmaceutici, Parma, Italy.
  • Papi A; Department of Respiratory Medicine and Translational Medicine, University of Ferrara, Ferrara, Italy.
  • Brightling C; Institute for Lung Health, National Institute for Health Research Biomedical Research Centre, University of Leicester, Leicester, UK.
  • Singh D; Centre for Respiratory Medicine and Allergy, University of Manchester, Manchester University NHS Foundation Trust, Manchester, UK.
  • van der Molen T; Groningen Research Institute for Asthma and COPD, University of Groningen, University Medical Center Groningen, Groningen, Netherlands; Department of General Practice and Elderly Care Medicine, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
  • Dahlén SE; Institute of Environmental Medicine and Centre for Allergy Research, Karolinska Institutet, Stockholm, Sweden.
  • Agusti A; Instituto de Investigaciones Biomédicas August Pi i Sunyer, Universitat de Barcelona, Barcelona, Spain; Respiratory Institute, Universitat de Barcelona, Barcelona, Spain.
  • Faner R; Instituto de Investigaciones Biomédicas August Pi i Sunyer, Universitat de Barcelona, Barcelona, Spain.
  • Wedzicha JA; National Heart and Lung Institute, Imperial College London, London, UK.
  • Donaldson GC; National Heart and Lung Institute, Imperial College London, London, UK.
  • Adcock IM; National Heart and Lung Institute, Imperial College London, London, UK.
  • Lahousse L; Department of Bioanalysis, Ghent University, Ghent, Belgium.
  • Kerstjens HAM; Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, Netherlands; Groningen Research Institute for Asthma and COPD, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
  • van den Berge M; Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, Netherlands; Groningen Research Institute for Asthma and COPD, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
Lancet Respir Med ; 11(1): 55-64, 2023 01.
Article em En | MEDLINE | ID: mdl-35907424
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Broncodilatadores Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Broncodilatadores Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article